ASAS recommendations for the approach to collection of NSAID intake for use in clinical trials/epidemiological studies of spondyloarthritis
| NSAID intake since the last visit | Yes □ | No □ | ||
|---|---|---|---|---|
| NSAID name | Average daily intake | Days with intake | Starting date | Ending date |
| □ <1 day/week | ||||
| □ 1–3 days/week | ||||
| ……………… | I___I___I___I mg | □ 3–5 days/week | I__I__II__I__II__I__I | I__I__II__I__II__I__Iθ |
| □ ≥5 days/week | Ongoing | |||
| □ Everyday | ||||
ASAS, Assessment of Spondyloarthritis International Society; NSAID, non-steroidal anti-inflammatory drug.